WallStSmart

Sitime Corporation (SITM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sitime Corporation generates 26% more annual revenue ($326.66M vs $258.90M). SITM leads profitability with a -13.1% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

SITM

Avoid

32

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 4.0Quality: 7.8
Piotroski: 5/9

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SITM.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SITM2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
66.3%10/10

Revenue surging 66.3% year-over-year

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SITM4 concerns · Avg: 2.8/10
Price/BookValuation
12.8x4/10

Trading at 12.8x book value

Operating MarginProfitability
2.6%3/10

Operating margin of 2.6%

PEG RatioValuation
3.822/10

Expensive relative to growth rate

Return on EquityProfitability
-4.6%2/10

ROE of -4.6% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : SITM

The strongest argument for SITM centers on Revenue Growth, Debt/Equity. Revenue growth of 66.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SITM

The primary concerns for SITM are Price/Book, Operating Margin, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SITM carries more volatility with a beta of 2.57 — expect wider price swings.

SITM is growing revenue faster at 66.3% — sustainability is the question.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 32/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Sitime Corporation

TECHNOLOGY · SEMICONDUCTORS · USA

SiTime Corporation offers silicon timing systems in Taiwan, Hong Kong, the United States, and internationally.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?